Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pharmaceutical Innovations, Inc. is a pioneering medical products company best known for developing the world's first medical ultrasound gel in 1965. Based in Newark, New Jersey, the company specializes in the research, development, and manufacture of conductive media, including gels, sprays, and lotions essential for diagnostic and therapeutic medical procedures. Its flagship brands, such as Ultra/Phonic and Scan, are industry standards used globally in hospitals and clinics for ultrasound, ECG/EKG, and electrosurgery. The company focuses on producing hypoallergenic, non-staining, and acoustically correct formulations that ensure patient safety and high-quality signal transmission. As a private, family-owned enterprise, it remains a critical supplier for the diagnostic imaging and cardiology sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pharmaceutical Innovations.